Established by leading executives and innovators in the field of molecular laboratories and personalized medicine, Labarium seeks to grow through strategic acquisitions of high-performing, compliant clinical laboratories across the United States to deliver its proprietary platforms to improve healthcare decisions. Though the company acquires and operates clinical laboratories, Labarium understands that it is an information company advancing healthcare to become more predictive and personalized. To do this, Labarium provides intelligent diagnostic, prognostic, and treatment-defining information from its laboratories that turn "commodity" lab testing into more meaningful and actionable information to improve up to 80% of medical decisions informed by laboratory tests. By improving these healthcare decisions, Labarium supports better and more personalized care, lower costs, better outcomes, superior research, more targeted treatments, and reduced risk.
Company Details
- Employees
- 3
- Founded
- 2024
- Address
- 495 Grand Boulevard,
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://www.labarium.com
- Keywords
- Dallas.
- HQ
- Miramar Beach, Florida
Labarium Questions
Labarium's website is https://www.labarium.com
Labarium's LinkedIn profile is https://www.linkedin.com/company/labarium
Labarium has
3 employees.
View email and phone details for 3
employees at Labarium.
Labarium's industry is
Medical and Diagnostic Laboratories
Labarium's top competitors are
Profound Ventures, Llc,
Cache Dna,
Coopervision Specialty Americas,
Phenomics Health,
Proove Genomics Inc.,
Dccs Consulting,
Orca Ai,
Mercedes-Benz Of Ontario,
Myome,
Dtr Labs.
Labarium's categories are Medical and Diagnostic Laboratories
Labarium's founding year is 2024
